Anke Geick
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 5
- Drug Transport and Resistance Mechanisms 3
- Cancer-related Molecular Pathways 1
-
- RNA Interference and Gene Delivery 3
- Cell death mechanisms and regulation 3
- Co-authors
- Michel F Eichelbaum (3 shared papers)Oliver Burk (3 shared papers)Heike Tegude (1 shared paper)Robert Homer (1 shared paper)Jack Angel Elias (1 shared paper)Antonin R. de Fougerolles (1 shared paper)Jonathan H. Nedrelow (1 shared paper)Lorraine B. Ware (1 shared paper)
- Journals
- FEBS Letters (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Current Protocols in Molecular Biology (1 paper)Nature Medicine (1 paper)Molecular Therapy (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Anke Geick
12 papers receiving 3.1k citations
Anke Geick's Hit Papers
Peers
Comparison fields: 5 of 100
- Pharmacology 379
- Oncology 676
- Molecular Biology 1.8k
- Cancer Research 127
- Biomaterials 94
Countries citing papers authored by Anke Geick
This map shows the geographic impact of Anke Geick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Geick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Geick more than expected).
Fields of papers citing papers by Anke Geick
This network shows the impact of papers produced by Anke Geick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Geick. The network helps show where Anke Geick may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Geick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Hit paper breakdown → | 2004 | 1884 |
| 2 | 2001 | 737 | |
| 3 | 2006 | 292 | |
| 4 | 2005 | 129 | |
| 5 | 1996 | 54 | |
| 6 | 2003 | 51 | |
| 7 | 2001 | 42 | |
| 8 | 2011 | 40 | |
| 9 | 2002 | 39 | |
| 10 | 2007 | 24 | |
| 11 | 2001 | 10 | |
| 12 | 2003 | 6 |
About Anke Geick
Anke Geick is a scholar working on Oncology, Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 12 papers that have together received 3.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), Cell death mechanisms and regulation (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Lung Cancer Treatments and Mutations (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Carcinogens and Genotoxicity Assessment (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Pharmacology (379 citations), Oncology (676 citations), Molecular Biology (1.8k citations), Cancer Research (127 citations) and Biomaterials (94 citations). Anke Geick has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Michel F Eichelbaum, Oliver Burk, Heike Tegude, Robert Homer, Jack Angel Elias, Antonin R. de Fougerolles, Jonathan H. Nedrelow, Lorraine B. Ware, Geoffrey Lowell Chupp and Patty J. Lee. Their work appears in journals such as FEBS Letters, Clinical Pharmacology & Therapeutics, Current Protocols in Molecular Biology, Nature Medicine and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.